As state legislators debate prescription drug reform this spring, the Illinois Primary Health Care Association, on behalf of Illinois’ 56 community health centers, is proposing legislation to end unnecessary and unfair restrictions on prescription drug discounts through the 340B program. During IPHCA’s annual lobby day at the Capitol, members from across the state will be discussing this vital program that benefits uninsured and low-income patients at no cost to taxpayers. The proposed Illinois Patient Access to 340B Pharmacy Protection Act is Senate Bill 2385, sponsored by Sen. Dave Koehler, and House Bill 3350, sponsored by Rep. Anna Moeller. Recently, pharmaceutical companies have imposed restrictions on the 340B program that hurt patients and the centers where they receive care. The Illinois Patient Access to 340B Pharmacy Protection Act legislation is modeled after efforts that have passed in eight other states, including Arkansas, which saw its law upheld by the U.S. Supreme Court. The legislation has no cost through state or federal funding, but simply prohibits drug companies from prohibiting, restricting, or interfering with local pharmacies’ participation in 340B programs. For more information, visit https://www.iphca.org/.